PHARMACOKINETICS OF DIGOXIN - INTERPRETING BIOAVAILABILITY

被引:64
作者
SANCHEZ, N [1 ]
SHEINER, LB [1 ]
HALKIN, H [1 ]
MELMON, KL [1 ]
机构
[1] UNIV CALIF,MED CTR,DEPT MED,DIV CLIN PHARMACOL,SAN FRANCISCO M-1089,CA 94143
关键词
D O I
10.1136/bmj.4.5885.132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:132 / 134
页数:3
相关论文
共 16 条
[1]  
BINNION PF, 1972, LANCET, V2, P592
[2]  
BUTLER V P JR, 1972, Progress in Cardiovascular Diseases, V14, P571, DOI 10.1016/0033-0620(72)90009-6
[3]   RELATION BETWEEN MYOCARDIAL H-3-DIGOXIN CONCENTRATION AND ITS HEMODYNAMIC EFFECTS [J].
DEUTSCHER, RN ;
GOLDMAN, RH ;
HARRISON, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1972, 29 (01) :47-+
[4]  
DITTERT LW, 1972, GUIDELINES BIOPHARMA
[5]   CLINICAL PHARMACOLOGY OF DIGITALIS GLYCOSIDES - A REVIEW [J].
DOHERTY, JE .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1968, 255 (JUN) :382-&
[6]   TRITIATED DIGOXIN .17. EXCRETION AND TURNOVER TIMES IN NORMAL DONORS BEFORE AND AFTER NEPHRECTOMY AND IN PAIRED RECIPIENT OF KIDNEY AFTER TRANSPLANTATION [J].
DOHERTY, JE ;
DALRYMPLE, GV ;
FLANIGAN, WJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1972, 29 (04) :470-+
[7]   NEW INFORMATION REGARDING DIGITALIS METABOLISM [J].
DOHERTY, JE ;
HALL, WH ;
MURPHY, ML ;
BEARD, OW .
CHEST, 1971, 59 (04) :433-&
[8]  
HIBBLE AG, 1972, LANCET, V2, P90
[9]  
HUFFMAN DH, 1972, J AMER MED ASSOC, V222, P957, DOI 10.1001/jama.222.8.957
[10]   VARIATION IN BIOLOGIC AVAILABILITY OF DIGOXIN FROM 4 PREPARATIONS [J].
LINDENBAUM, J ;
MELLOW, MH ;
BLACKSTONE, MO ;
BUTLER, VP .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (24) :1344-+